Hei Yue Tina Fong
CIK: 0002009968
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NewGenIvf Group Ltd
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Oct 5, 2026NIVF
NewGenIvf Group Ltd
Exercise(M)Direct139.8K shares at avg. $0.00$13.981 - Aug 17, 2026NIVF
NewGenIvf Group Ltd
Award(A)DirectStock Options (Right to Buy)
272.1K shares- - Jul 8, 2026NIVF
NewGenIvf Group Ltd
Award(A)DirectEmployee Share Options
73.6K shares- - Jun 4, 2026NIVF
NewGenIvf Group Ltd
Exercise(M)Direct56.9K shares at avg. $0.00$5.685 - May 4, 2026NIVF
NewGenIvf Group Ltd
Award(A)DirectStock Options (Right to Buy)
56.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 5, 2026 | NIVF NewGenIvf Group Ltd | Exercise(M) | 139,811 | $0.00 | $14 | Direct |
| Aug 17, 2026 | NIVF NewGenIvf Group Ltd | Award(A) Stock Options (Right to Buy) | 272,140 | - | - | Direct |
| Jul 8, 2026 | NIVF NewGenIvf Group Ltd | Award(A) Employee Share Options | 73,647 | - | - | Direct |
| Jun 4, 2026 | NIVF NewGenIvf Group Ltd | Exercise(M) | 56,851 | $0.00 | $6 | Direct |
| May 4, 2026 | NIVF NewGenIvf Group Ltd | Award(A) Stock Options (Right to Buy) | 56,851 | - | - | Direct |
1-5 of 5 transactions
About Fong Hei Yue Tina
Fong Hei Yue Tina (SEC CIK 0002009968) files insider reports with the SEC as Chief Marketing Officer of NewGenIvf Group Ltd (NIVF).
Signal8 holds 6 ownership filings by Fong Hei Yue Tina (1 Form 3, 5 Form 4), filed between Mar 27, 2026 and Oct 6, 2026. Those filings report 5 transactions, from May 4, 2026 to Oct 5, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Fong Hei Yue Tina's filings is in HONG KONG.
Recent filings by Fong Hei Yue Tina
- Oct 5, 2026: Option exercise of NIVF shares (Form 4, code M).
- Aug 17, 2026: Grant or award of NIVF derivative securities (Form 4, code A).
- Jul 8, 2026: Grant or award of NIVF derivative securities (Form 4, code A).
- Jun 4, 2026: Option exercise of NIVF shares (Form 4, code M).
- May 4, 2026: Grant or award of NIVF derivative securities (Form 4, code A).
Other insiders filing for NewGenIvf Group Ltd (NIVF)
- Siu Wing Fung Alfred, Chairman & CEO
- Lau Tsz Hin Vincent, Director
- Lam Chun Tung Patrick, Director
- Cheung Kong Yiu, Director
- Lee Sze Mun, Director
- Chung Ho Fai, Chief Financial Officer